OTC · RENEF
Cartesian Growth Corporation II
$12.71$0.00 (0.0%)
Cartesian Growth Corporation II’s quoted price sits in the upper half of its reported 52-week range, 4.94% below the high.
Loading market information…
NASDAQ · HSAQ · USD
Stock price, earnings
Quote as of Jan 26, 2023, 08:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Health Sciences Acquisitions Corporation 2’s quoted price sits in the upper half of its reported 52-week range, 3.55% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Health Sciences Acquisitions Corporation 2’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Health Sciences Acquisitions Corporation 2 currently lacks active business operations. Its primary objective is to complete a strategic business combination, such as a merger or acquisition, with one or more enterprises. These target businesses will operate within the biopharmaceutical or medical technology sectors and be located in North America or Europe. The company was established in 2020 and is headquartered in New York, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:45 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$12.71$0.00 (0.0%)
Cartesian Growth Corporation II’s quoted price sits in the upper half of its reported 52-week range, 4.94% below the high.
$11.08-$0.04 (-0.36%)
Ross Acquisition Corp II’s quoted price sits in the upper half of its reported 52-week range, 0.36% below the high.
$10.43$0.00 (0.0%)
LAVA Medtech Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 3.87% below the high.
$11.58$0.00 (0.0%)
Blockchain Coinvestors Acquisition Corp. I: Financial Services · Shell Companies.
$17.57+$0.21 (+1.21%)
HPX Corp.’s quoted price sits in the lower half of its reported 52-week range, 65.21% below the high.
$11.07-$0.93 (-7.75%)
10X Capital Venture Acquisition Corp. III’s quoted price sits in the lower half of its reported 52-week range, 14.78% below the high.
$10.54+$0.01 (+0.1%)
Landcadia Holdings IV, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.19% below the high.
$17.44-$6.91 (-28.37%)
Aurora Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 72.27% below the high.
